Lauren Glenn

ORCID: 0000-0003-0263-4149
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Injury Epidemiology and Prevention
  • Poisoning and overdose treatments
  • Neurogenetic and Muscular Disorders Research
  • RNA regulation and disease
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Blood Coagulation and Thrombosis Mechanisms
  • Restraint-Related Deaths
  • Protein Degradation and Inhibitors

Regen BioPharma (United States)
2015

Columbia University
2014

<h3>Objective:</h3> To quantify change in symptoms over time using home-based gait and mobility assessments from a prospective natural history study of patients with adrenomyeloneuropathy (AMN). <h3>Background:</h3> AMN is rare neurodegenerative disorder the brain spinal cord affecting adults mutations <i>ABCD1</i> gene. Quantification disease progression challenging, owing to phenotypic variability. One solution address this measure traditional functional motor tasks more frequently...

10.1212/wnl.0000000000201912 article EN Neurology 2023-04-25
Coming Soon ...